BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) Stock Fundamental Analysis
USA - NASDAQ:BRKRP - US1167942077
308.55 USD
-1.83 (-0.59%)
307 USD
-1.55 (-0.5%)
Taking everything into account, BRKRP scores 4 out of 10 in our fundamental rating. BRKRP was compared to 58 industry peers in the Life Sciences Tools & Services industry. While BRKRP is still in line with the averages on profitability rating, there are concerns on its financial health. BRKRP is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year BRKRP was profitable.
BRKRP had a positive operating cash flow in the past year.
In the past 5 years BRKRP has always been profitable.
BRKRP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 1.26%, BRKRP is doing good in the industry, outperforming 63.79% of the companies in the same industry.
BRKRP's Return On Equity of 4.41% is fine compared to the rest of the industry. BRKRP outperforms 67.24% of its industry peers.
The Return On Invested Capital of BRKRP (4.48%) is better than 67.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BRKRP is below the industry average of 13.49%.
The last Return On Invested Capital (4.48%) for BRKRP is well below the 3 year average (9.30%), which needs to be investigated, but indicates that BRKRP had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROIC | 4.48% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
BRKRP's Profit Margin of 2.31% is fine compared to the rest of the industry. BRKRP outperforms 63.79% of its industry peers.
In the last couple of years the Profit Margin of BRKRP has declined.
Looking at the Operating Margin, with a value of 9.69%, BRKRP is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
In the last couple of years the Operating Margin of BRKRP has declined.
With a Gross Margin value of 48.54%, BRKRP perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Gross Margin of BRKRP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKRP is destroying value.
The number of shares outstanding for BRKRP has been increased compared to 1 year ago.
Compared to 5 years ago, BRKRP has less shares outstanding
Compared to 1 year ago, BRKRP has a worse debt to assets ratio.
2.2 Solvency
BRKRP has an Altman-Z score of 7.60. This indicates that BRKRP is financially healthy and has little risk of bankruptcy at the moment.
BRKRP has a Altman-Z score of 7.60. This is amongst the best in the industry. BRKRP outperforms 87.93% of its industry peers.
BRKRP has a debt to FCF ratio of 49.40. This is a negative value and a sign of low solvency as BRKRP would need 49.40 years to pay back of all of its debts.
With a Debt to FCF ratio value of 49.40, BRKRP perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
BRKRP has a Debt/Equity ratio of 1.32. This is a high value indicating a heavy dependency on external financing.
BRKRP has a worse Debt to Equity ratio (1.32) than 81.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Altman-Z | 7.6 |
ROIC/WACC0.43
WACC10.32%
2.3 Liquidity
BRKRP has a Current Ratio of 1.61. This is a normal value and indicates that BRKRP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of BRKRP (1.61) is worse than 67.24% of its industry peers.
BRKRP has a Quick Ratio of 1.61. This is a bad value and indicates that BRKRP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.68, BRKRP is not doing good in the industry: 89.66% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 |
3. Growth
3.1 Past
The earnings per share for BRKRP have decreased strongly by -16.99% in the last year.
The Earnings Per Share has been growing by 8.95% on average over the past years. This is quite good.
BRKRP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.36%.
BRKRP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
3.2 Future
The Earnings Per Share is expected to grow by 5.99% on average over the next years.
Based on estimates for the next years, BRKRP will show a small growth in Revenue. The Revenue will grow by 2.74% on average per year.
EPS Next Y-17.04%
EPS Next 2Y-1.76%
EPS Next 3Y5%
EPS Next 5Y5.99%
Revenue Next Year2.63%
Revenue Next 2Y2.07%
Revenue Next 3Y3.3%
Revenue Next 5Y2.74%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
BRKRP is valuated quite expensively with a Price/Earnings ratio of 143.51.
The rest of the industry has a similar Price/Earnings ratio as BRKRP.
The average S&P500 Price/Earnings ratio is at 26.76. BRKRP is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 132.65 indicates a quite expensive valuation of BRKRP.
BRKRP's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of BRKRP to the average of the S&P500 Index (22.63), we can say BRKRP is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 143.51 | ||
| Fwd PE | 132.65 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as BRKRP.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRKRP is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 949.56 | ||
| EV/EBITDA | 90.36 |
4.3 Compensation for Growth
BRKRP has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)16.04
EPS Next 2Y-1.76%
EPS Next 3Y5%
5. Dividend
5.1 Amount
With a yearly dividend of 0.50%, BRKRP is not a good candidate for dividend investing.
BRKRP's Dividend Yield is rather good when compared to the industry average which is at 0.47. BRKRP pays more dividend than 93.10% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, BRKRP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
5.2 History
The dividend of BRKRP has a limited annual growth rate of 4.81%.
BRKRP is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)4.81%
Div Incr YearsN/A
Div Non Decr YearsN/A
5.3 Sustainability
BRKRP pays out 38.32% of its income as dividend. This is a sustainable payout ratio.
The dividend of BRKRP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP38.32%
EPS Next 2Y-1.76%
EPS Next 3Y5%
308.55
-1.83 (-0.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.43%
Inst Owner ChangeN/A
Ins Owners26.98%
Ins Owner ChangeN/A
Market Cap46.81B
Revenue(TTM)3.44B
Net Income(TTM)79.60M
Analysts76.19
Price Target387.04 (25.44%)
Short Float %0%
Short Ratio0.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.5% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP38.32%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.72%
Min EPS beat(2)-26.01%
Max EPS beat(2)6.57%
EPS beat(4)2
Avg EPS beat(4)-4.79%
Min EPS beat(4)-26.01%
Max EPS beat(4)6.57%
EPS beat(8)5
Avg EPS beat(8)2.53%
EPS beat(12)9
Avg EPS beat(12)4.53%
EPS beat(16)11
Avg EPS beat(16)6.67%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)2.76%
Revenue beat(4)1
Avg Revenue beat(4)-0.72%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)0.99%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.29%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.51%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 143.51 | ||
| Fwd PE | 132.65 | ||
| P/S | 13.6 | ||
| P/FCF | 949.56 | ||
| P/OCF | 282.18 | ||
| P/B | 25.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 90.36 |
EPS(TTM)2.15
EY0.7%
EPS(NY)2.33
Fwd EY0.75%
FCF(TTM)0.32
FCFY0.11%
OCF(TTM)1.09
OCFY0.35%
SpS22.69
BVpS11.89
TBVpS-5.37
PEG (NY)N/A
PEG (5Y)16.04
Graham Number23.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.26% | ||
| ROE | 4.41% | ||
| ROCE | 6.68% | ||
| ROIC | 4.48% | ||
| ROICexc | 4.57% | ||
| ROICexgc | 9.81% | ||
| OM | 9.69% | ||
| PM (TTM) | 2.31% | ||
| GM | 48.54% | ||
| FCFM | 1.43% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.32 | ||
| Debt/FCF | 49.4 | ||
| Debt/EBITDA | 4.37 | ||
| Cap/Depr | 55.42% | ||
| Cap/Sales | 3.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 30.5% | ||
| Profit Quality | 61.93% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 0.68 | ||
| Altman-Z | 7.6 |
F-Score5
WACC10.32%
ROIC/WACC0.43
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.99%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-38.46%
EPS Next Y-17.04%
EPS Next 2Y-1.76%
EPS Next 3Y5%
EPS Next 5Y5.99%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.41%
Revenue Next Year2.63%
Revenue Next 2Y2.07%
Revenue Next 3Y3.3%
Revenue Next 5Y2.74%
EBIT growth 1Y-20.95%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year15.58%
EBIT Next 3Y13.09%
EBIT Next 5Y8.93%
FCF growth 1Y-75.44%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-51.42%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP - BRKR 6 3/8 09/01/28 / BRKRP FAQ
What is the fundamental rating for BRKRP stock?
ChartMill assigns a fundamental rating of 4 / 10 to BRKRP.
Can you provide the valuation status for BRUKER CORP - BRKR 6 3/8 09/01/28?
ChartMill assigns a valuation rating of 2 / 10 to BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP - BRKR 6 3/8 09/01/28?
BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) has a profitability rating of 6 / 10.
What is the valuation of BRUKER CORP - BRKR 6 3/8 09/01/28 based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is 143.51 and the Price/Book (PB) ratio is 25.95.
Can you provide the expected EPS growth for BRKRP stock?
The Earnings per Share (EPS) of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is expected to decline by -17.04% in the next year.